Arcutis Biotherapeutics (ARQT) Amortizatization of Intangibles (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Amortizatization of Intangibles of $182000.0 for Q1 2026, down 78.81% year-over-year from $859000.0 in Q1 2025, and up 1754.55% quarter-over-quarter from -$11000.0 in Q4 2025.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $182000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 78.81% year-over-year to $182000.0; the TTM figure through Mar 2026 stood at $1.4 million (down 76.52% YoY), while the FY2025 annual figure was $2.1 million, down 69.66% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $182000.0, up from -$11000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $2.4 million in Q2 2024, with the low at -$618000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $1.1 million (2024), against an average of $1.1 million.
- The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles surged 770.59% in 2023, then plunged 101.0% in 2025.
- Arcutis Biotherapeutics' Amortizatization of Intangibles stood at $2.3 million in 2022, then sank by 37.15% to $1.5 million in 2023, then declined by 25.54% to $1.1 million in 2024, then sank by 101.0% to -$11000.0 in 2025, then jumped by 1754.55% to $182000.0 in 2026.
- Business Quant data shows ARQT's Amortizatization of Intangibles at $182000.0 in Q1 2026, -$11000.0 in Q4 2025, and $551000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Arcutis Biotherapeutics | 3.12 Bn | 2.88 Bn | 118.92 Mn | 223,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 223,000.00 |
| Mar 31, 2026 | 182,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Sep 30, 2025 | 551,000.00 |
| Jun 30, 2025 | 695,000.00 |
| Mar 31, 2025 | 859,000.00 |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | 2.16 Mn |
| Dec 31, 2022 | 2.02 Mn |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | -272,000.00 |
| Mar 31, 2022 | -618,000.00 |
| Dec 31, 2021 | -885,000.00 |
| Sep 30, 2021 | -1.15 Mn |